Actualités Protagonist Therapeutics - PTGX

Les meilleurs offres pour accéder les cours en temps réel en illimité
Real-time Level 1 for Canada + USA
Abonnement Mensuel
Seulement
32,99 €
Trader
Abonnement Mensuel
Seulement
34,09 €
Expert
Abonnement Mensuel
Seulement
92,39 €
Prix hors taxes
Nom Action Symbole Action Marché Type
Protagonist Therapeutics Inc PTGX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Plus Bas Plus Haut Ouverture Clôture Veille Dernier échange
-0,06 -0,96% 6,19 6,00 6,34 6,22 6,25 22:30:00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
23/3/202023:15EDGARStatement of Changes in Beneficial Ownership (4)
18/3/202021:43EDGARCurrent Report Filing (8-k)
13/3/202018:05EDGARStatement of Changes in Beneficial Ownership (4)
13/3/202000:27EDGARStatement of Changes in Beneficial Ownership (4)
10/3/202022:25EDGARSecurities Registration: Employee Benefit Plan (s-8)
10/3/202022:19EDGARAnnual Report (10-k)
10/3/202021:06EDGARCurrent Report Filing (8-k)
10/3/202021:01PRNUSProtagonist Therapeutics Reports Fourth Quarter and Full..
02/3/202022:30PRNUSProtagonist Therapeutics to Announce Fourth Quarter and Full..
29/2/202000:16EDGARStatement of Changes in Beneficial Ownership (4)
29/2/202000:16EDGARStatement of Changes in Beneficial Ownership (4)
29/2/202000:16EDGARStatement of Changes in Beneficial Ownership (4)
29/2/202000:16EDGARStatement of Changes in Beneficial Ownership (4)
29/2/202000:15EDGARStatement of Changes in Beneficial Ownership (4)
24/2/202022:06EDGARCurrent Report Filing (8-k)
19/2/202013:00PRNUSProtagonist Therapeutics to Present at the SVB Leerink 9th..
14/2/202022:22EDGARAmended Statement of Ownership (sc 13g/a)
14/2/202022:05EDGARAmended Statement of Ownership (sc 13g/a)
14/2/202020:40EDGARAmended Statement of Ownership (sc 13g/a)
14/2/202019:27EDGARAmended Statement of Ownership (sc 13g/a)
14/2/202012:20EDGARAmended Statement of Ownership (sc 13g/a)
07/2/202017:29EDGARAmended Statement of Ownership (sc 13g/a)
07/2/202014:46EDGARStatement of Ownership (sc 13g)
07/2/202013:00PRNUSProtagonist Therapeutics to Present Preclinical Results on..
07/1/202013:00PRNUSProtagonist Therapeutics Achieves Milestone in Janssen..
06/1/202013:00PRNUSProtagonist Therapeutics Initiates Phase 2 Study of Novel..
16/12/201917:07EDGARStatement of Ownership (sc 13g)
04/12/201900:46EDGARStatement of Changes in Beneficial Ownership (4)
04/12/201900:33EDGARStatement of Changes in Beneficial Ownership (4)
04/12/201900:12EDGARStatement of Changes in Beneficial Ownership (4)
04/12/201900:11EDGARStatement of Changes in Beneficial Ownership (4)
03/12/201913:51EDGARCurrent Report Filing (8-k)
03/12/201913:00PRNUSProtagonist Therapeutics Announces Preliminary Phase 2..
27/11/201923:20EDGARCurrent Report Filing (8-k)
27/11/201923:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
27/11/201920:59EDGARStatement of Changes in Beneficial Ownership (4)
25/11/201912:05EDGARNotice of Effectiveness (effect)
13/11/201913:00PRNUSProtagonist Therapeutics to Present at Two Upcoming..
06/11/201923:13EDGARQuarterly Report (10-q)
06/11/201922:35EDGARCurrent Report Filing (8-k)
06/11/201922:30PRNUSProtagonist Therapeutics Reports Third Quarter 2019..
06/11/201922:01PRNUSProtagonist Therapeutics Announces First Patient Dosed in a..
31/10/201922:26EDGARSecurities Registration Statement (simplified Form) (s-3)
31/10/201921:52EDGARCurrent Report Filing (8-k)
31/10/201912:00PRNUSProtagonist Therapeutics Secures Debt Facility for up to $50..
30/10/201921:49PRNUSProtagonist Therapeutics Initiates Phase 2 Study of Novel..
01/10/201913:00PRNUSProtagonist Therapeutics Announces Acceptance of Abstracts..
25/9/201913:00PRNUSProtagonist Therapeutics to Present at the Cantor Global..
04/9/201922:30PRNUSProtagonist Therapeutics Reports Granting of Inducement..
03/9/201922:30PRNUSProtagonist Therapeutics to Present at the H.C. Wainwright &..
Voir d'autres actualités liées à cette action »
Dernières Valeurs Consultées
NASDAQ
PTGX
Protagonis..
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V: D:20200405 17:18:58